Literature DB >> 12917473

The most abundantly transcribed human cytomegalovirus gene (beta 2.7) is non-essential for growth in vitro.

Brian P McSharry1, Peter Tomasec1, M Lynne Neale2, Gavin W G Wilkinson1.   

Abstract

The most abundantly transcribed HCMV gene (beta 2.7) encodes a 2.7 kb polyadenylated RNA. Although the laboratory-adapted HCMV strains AD169 and Towne possess two copies of the beta 2.7 gene within an expanded b sequence element, the low passage strain Toledo and all clinical isolates analysed contain only a single copy located within the U(L) region. A beta 2.7 deletion mutant constructed based on a strain Toledo background was shown to replicate with kinetics comparable to those of the parental virus; the beta2.7 gene is therefore not essential for virus replication in vitro. Sequencing the beta 2.7 gene from HCMV clinical isolates and the Toledo strain reveals that although the overall gene sequence is highly conserved (>99 %), the RL4 frame originally assigned in strain AD169 was disrupted in each of these viruses. Consequently, the beta 2.7 transcript does not encode any obvious translation product and thus may not function as an mRNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917473     DOI: 10.1099/vir.0.19298-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus.

Authors:  Claire Gealy; Marian Denson; Christine Humphreys; Brian McSharry; Gavin Wilkinson; Richard Caswell
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

3.  Cytomegalovirus: pathogen, paradigm, and puzzle.

Authors:  Michael Boeckh; Adam P Geballe
Journal:  J Clin Invest       Date:  2011-05       Impact factor: 14.808

4.  Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.

Authors:  Angie K Marsh; David O Willer; Aruna P N Ambagala; Misko Dzamba; Jacqueline K Chan; Richard Pilon; Jocelyn Fournier; Paul Sandstrom; Michael Brudno; Kelly S MacDonald
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.

Authors:  Jitka Holcakova; Peter Tomasec; Joachim J Bugert; Eddie Cy Wang; Gavin Wg Wilkinson; Roman Hrstka; Vladimir Krystof; Miroslav Strnad; Borivoj Vojtesek
Journal:  Antivir Chem Chemother       Date:  2010-01-05

Review 6.  Roles of Non-coding RNAs During Herpesvirus Infection.

Authors:  Meaghan H Hancock; Rebecca L Skalsky
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

8.  Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens.

Authors:  Charles Cunningham; Derek Gatherer; Birgitta Hilfrich; Katarina Baluchova; Derrick J Dargan; Marian Thomson; Paul D Griffiths; Gavin W G Wilkinson; Thomas F Schulz; Andrew J Davison
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

Review 9.  Prevention of cellular suicide by cytomegaloviruses.

Authors:  Patricia M Fliss; Wolfram Brune
Journal:  Viruses       Date:  2012-10-02       Impact factor: 5.048

10.  Long non-coding RNAs (lncRNAs) and viral infections.

Authors:  Quan Zhang; Kuan-Teh Jeang
Journal:  Biomed Pharmacother       Date:  2013-03-01       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.